A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform.

Source:http://linkedlifedata.com/resource/pubmed/id/20038957

Download in:

View as

Triples

General Info

PMID
20038957